© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Top Medical News
NYU Langone’s Comprehensive Epilepsy Center Elevates Care Standards, Drug Development
August 05, 2021
By Marco Meglio
Led by a team of the top talents, NYU Langone’s Comprehensive Epilepsy Center’s contributions to drug development and improving the quality of life for patients stands alone.
Wearable Sensors Feasible for Automatic Seizure Detection
August 04, 2021
By Abby Reinhard
Preliminary results showed that a fusion of accelerometry and blood volume post modalities achieved the best AUC-ROC for 9 combined seizure types.
Interim Data on DNL310 Show Improvement in MPS II Symptoms
August 04, 2021
By Abby Reinhard
Results and safety data from the phase 1/2 study of the therapy for Hunter syndrome/MPS II were presented at MPS 2021, the 18th International Symposium on MPS and Released Diseases, on July 25.
Anti-CD20 Therapy for MS and NMOSD Linked to Lower COVID-19 Antibody Response
August 04, 2021
By Marco Meglio
Among independent variables including DMT group, time from COVID-19 infection, total IgG level, age, sex, obesity, and COVID-19 severity, only the anti-CD20 group was associated with decreased odds of positive serology.
NeuroVoices: Mike Detke, MD, PhD, on Atuzaginstat’s Potential in Alzheimer Disease, Periodontal Disease
August 04, 2021
By Marco Meglio
The chief medical officer of Cortexyme discussed the company’s investigational agent atuzaginstat, its mechanism of action, and the findings of the phase 2/3 GAIN trial.
